Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_assertion type Assertion NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_head.
- NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_assertion wasGeneratedBy ECO_0000203 NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_provenance.
- NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_assertion wasDerivedFrom befree-2016 NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_provenance.
- NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_assertion SIO_000772 21661378 NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_provenance.
- NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_assertion evidence source_evidence_literature NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_provenance.
- NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_provenance.